Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV-2 infection: Retrospective cohort study

Background: The use of cytokine-blocking agents has been proposed to modulate the inflammatory response in patients with COVID-19. Tocilizumab and anakinra were included in the local protocol as an optional treatment in critically ill patients with acute respiratory distress syndrome (ARDS) by SARS-CoV-2 infection. This cohort study evaluated the effects of therapy with cytokine blocking agents on in-hospital mortality in COVID-19 patients requiring mechanical ventilation and admitted to intensive care unit. Methods: The association between therapy with tocilizumab or anakinra and in-hospital mortality was assessed in consecutive adult COVID-19 patients admitted to our ICU with moderate to severe ARDS. The association was evaluated by comparing patients who received to those who did not receive tocilizumab or anakinra and by using different multivariable Cox models adjusted for variables related to poor outcome, for the propensity to be treated with tocilizumab or anakinra and after patient matching. Results: Sixty-six patients who received immunotherapy (49 tocilizumab, 17 anakinra) and 28 patients who did not receive immunotherapy were included. The in-hospital crude mortality was 30,3% in treated patients and 50% in non-treated (OR 0.77, 95% CI 0.56-1.05, p=0.069). The adjusted Cox model showed an association between therapy with immunotherapy and in-hospital mortality (HR 0.40, 95% CI 0.19-0.83, p=0.015). This protective effect was further confirmed in the analysis adjusted for propensity score, in the propensity-matched cohort and in the cohort of patients with invasive mechanical ventilation within 2 hours after ICU admission. Conclusions: Although important limitations, our study showed that cytokine-blocking agents seem to be safe and to improve survival in COVID-19 patients admitted to ICU with ARDS and the need for mechanical ventilation

Braiding kinetics and spectroscopy in photo-catalysis: the spectro-kinetic approach

[EN] The combination of kinetic and spectroscopic tools has become a key scientific methodology for the understanding of catalytic behavior but its application in photocatalysis has inherent difficulties due to the nature of the energy source of the reaction. This review article provides an overview of its use by, first, presenting mechanistically derived kinetic formulations and spectroscopic data handling methods including intrinsic expressions for light and, second, highlighting representative examples of application. To do it we consider universal catalytic systems, particularly (although not exclusively) titania-based materials, and the most frequent hole and/or electron triggered reaction schemes. This review also provides a general framework to pave the way for the future progress of the spectro-kinetic approach in the photocatalysis area.A. K., M. J. M.-B. and M. F.-G. thank MINECO (Spain) project ENE2016-77798-C4-1-R for financial support. M. J. M.-B. thanks MINECO for the award of postdoctoral JdC contract (Ref. FJCI- 2016-29014). O. M. A. and M. M. B. thank Universidad Nacional del Litoral (UNL, PIC50420150100009LI), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET, PIP-2015 0100093), and Agencia Nacional de Promoción Científica yTecnológica (ANPCyT, PICT-2015-2651) of Argentina for financial support